Skip to main content
. 2021 Dec 8;10(12):1587. doi: 10.3390/pathogens10121587

Figure 6.

Figure 6

Acquired drug resistance in Mexico City, 2020. (a) By drug class, (b) by individual drugs, (c) SDRM and non-SDRM. ADR was estimated from protease (PR), reverse transcriptase (RT) and integrase (IN) sequences using the Stanford HIVdb tool (v9.0). Individuals with HIV ADR were defined as those having a Stanford score ≥ 15 for any of the drugs in the corresponding category, as described in the Methods. ADR, acquired drug resistance; PI, protease inhibitors; RTI, reverse transcriptase inhibitors; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleoside reverse transcriptase inhibitors; INSTI, integrase strand-transfer inhibitors; EFV, efavirenz; NVP, nevirapine; ATV/r, atazanavir/ritonavir; DRV/r, darunavir/ritonavir; LPV/r, lopinavir/ritonavir; EVG, elvitegravir; RAL, raltegravir; BIC, bictegravir; CAB, cabotegravir; DTG, dolutegravir; DRM, drug resistance mutation; SDRM, surveillance DRM.